1. Home
  2. XRTX vs VMAR Comparison

XRTX vs VMAR Comparison

Compare XRTX & VMAR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • XRTX
  • VMAR
  • Stock Information
  • Founded
  • XRTX 2011
  • VMAR 1995
  • Country
  • XRTX Canada
  • VMAR Canada
  • Employees
  • XRTX N/A
  • VMAR N/A
  • Industry
  • XRTX Pharmaceuticals and Biotechnology
  • VMAR Marine Transportation
  • Sector
  • XRTX Health Care
  • VMAR Industrials
  • Exchange
  • XRTX Nasdaq
  • VMAR Nasdaq
  • Market Cap
  • XRTX 4.4M
  • VMAR 4.5M
  • IPO Year
  • XRTX N/A
  • VMAR 2020
  • Fundamental
  • Price
  • XRTX $0.62
  • VMAR $1.20
  • Analyst Decision
  • XRTX
  • VMAR
  • Analyst Count
  • XRTX 0
  • VMAR 0
  • Target Price
  • XRTX N/A
  • VMAR N/A
  • AVG Volume (30 Days)
  • XRTX 154.7K
  • VMAR 261.1K
  • Earning Date
  • XRTX 11-17-2025
  • VMAR 01-12-2026
  • Dividend Yield
  • XRTX N/A
  • VMAR N/A
  • EPS Growth
  • XRTX N/A
  • VMAR N/A
  • EPS
  • XRTX N/A
  • VMAR N/A
  • Revenue
  • XRTX N/A
  • VMAR $1,128,568.00
  • Revenue This Year
  • XRTX N/A
  • VMAR N/A
  • Revenue Next Year
  • XRTX N/A
  • VMAR $264.29
  • P/E Ratio
  • XRTX N/A
  • VMAR N/A
  • Revenue Growth
  • XRTX N/A
  • VMAR N/A
  • 52 Week Low
  • XRTX $0.52
  • VMAR $1.10
  • 52 Week High
  • XRTX $1.79
  • VMAR $39.00
  • Technical
  • Relative Strength Index (RSI)
  • XRTX 47.57
  • VMAR 41.14
  • Support Level
  • XRTX $0.52
  • VMAR $1.10
  • Resistance Level
  • XRTX $0.61
  • VMAR $1.58
  • Average True Range (ATR)
  • XRTX 0.05
  • VMAR 0.10
  • MACD
  • XRTX 0.01
  • VMAR -0.00
  • Stochastic Oscillator
  • XRTX 84.08
  • VMAR 21.44

About XRTX XORTX Therapeutics Inc.

XORTX Therapeutics Inc is a clinical-stage biotechnology company focused on identifying, developing, and potentially commercializing therapies to treat progressive kidney disease modulated by aberrant purine and uric acid metabolism and uric acid metabolism in orphan (rare) disease indications such as ADPKD and T2DN, as well as AKI associated with respiratory virus infection. Its focus is on developing three therapeutic products to slow or reverse the progression of chronic kidney disease, address the immediate need of individuals facing AKI associated with respiratory virus infection, and identify other opportunities where existing and new intellectual property can be leveraged to address health issues.

About VMAR Vision Marine Technologies Inc.

Vision Marine Technologies Inc is in the business of designing and manufacturing electric outboard powertrain systems, power boats, and related technology and the renting of electric boats. The different models of the powerboats and electric boats manufactured by the company include Bruce 22, Fantail 217, Volt 180, and others. The company operates in two reportable business segments; Sale of electric boats and Rental of electric boats. The majority of the revenue for the company is generated from the Sale of electric boats segment. Geographically, the company generates revenue from its business in Canada, USA and other countries. A substantial portion of the overall revenue is generated from its business in USA.

Share on Social Networks: